Ecto
Ecto is a digital biology company developing technology to make protein production more efficient and sustainable
About Ecto
Ecto develops technology at the intersection of data and biology to enable a more efficient and sustainable aquaculture industry. They collaborate with farmers to streamline production and health management by leveraging advanced molecular tools and digital technologies. To date, Ecto's solutions have enabled farmers to create 51,510,714 additional healthy servings of protein. Ecto has offices in Boston, Atlanta, and Stavanger Norway, and serves customers all over the world. The company was founded at Harvard Innovation Labs in 2013 by Dmitry Kozachenok and James Webb. The company has received competitive research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway.
Company Facts
- Headquarters
- Atlanta
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Total Funding
- $13,578,612
- Last Funding Type
- series_unknown
- Last Funding Date
- 2023-10-20
- Website
- ecto.com
Industries & Categories
Aquaculture, Biotechnology, Health Diagnostics, Information Technology
Social Links
Canonical: https://fsome.com/organization/ecto-108519 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.